Mesothelioma trials in Italy

In Italy 14 Also abroad 104

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in Italy
Phase II study of SErtraline in combination with cisplatin or carboplatin and pemetrexed as treatment in advanced, not resectable epithelioid pleural MEsothelioma (MESE study).
Where
Aviano, Trieste, Udine
Age
18 years and over
People
83
Run by
Centro Di Riferimento Oncologico Di Aviano
See details and how to join2026-526791-23-00 · EU 2026-526791-23-00
Phase 3Taking people
PHASE III STUDY WITH ATEZOLIZUMAB VERSUS PLACEBO IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS AFTER PLEURECTOMY/DECORTICATION
Where
Alessandria, Bari, Ferrara, Genova-Sampierdarena, Meldola, Modena, Orbassano, Padova, Parma, Pavia, Reggio Emilia, Rozzano, Statte, Trieste
Age
18 years and over
People
81
Run by
G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica
See details and how to join2024-519286-21-00 · EU 2024-519286-21-00
Phase 1Not yet taking people in Italy
A Phase I dose escalation study of intrapleural administration of Oncofid-P-M in patients with unresectable recurrent/progressive pleural mesothelioma after first-line treatment
Where
Padova
Age
18 years and over
People
30
Run by
Fidia Farmaceutici S.p.A.
See details and how to join2026-526119-12-00 · EU 2026-526119-12-00
Phase 2Taking people
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Where
Alexandria, Bergamo, Orbassano
Age
18 years to 64 years
People
257 worldwide
Run by
AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00
Phase 1/2Taking people
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Where
Bologna, Milan, Rome, Rozzano
Age
18 years and over
People
300 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00
Phase 2Not yet taking people in Italy
A Phase II, Open-Label, Single Arm, prospective, multicenter study of niraparib plus dostarlimab in patients with pleural mesothelioma positive for PD-L1 expression and germline or somatic mutations in the HRR genes
Where
Acquaviva delle Fonti, Aviano, Bari, Catania, Florence, Genoa, Lecce, Meldola, Messina, Monza, Naples, Orbassano, Padova, Pavia, Pesaro, Reggio Emilia, Varese, IRCCS Istituti Fisioterapici Ospitalieri- Istituto Nazionale tumori Regina Elena
Age
18 years and over
People
48
Run by
Universita' Degli Studi Di Torino
See details and how to joinNCT04940637 · EU 2024-515555-38-01
No phaseTaking people
Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
Where
Catania, Naples, Reggio Emilia, Roma
Age
18 years and over
People
300
Run by
Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT07561190
No phaseTaking people
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Where
Palermo, Perugia
Age
1 year and over
People
300
Run by
Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07403630
No phaseTaking people
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Where
Alessandria, Bergamo
Age
18 years and over
People
198 worldwide
Run by
NovoCure Ltd.
See details and how to joinNCT05538806
No phaseTaking people
An International Study on Pediatric Patients With Rare Tumors.
Where
Padova
Age
0 years to 18 years
People
6,250
Run by
Azienda Ospedaliera di Padova
See details and how to joinNCT07072143
No phaseTaking people
Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS
Where
Pavia
Age
18 years and over
People
60
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06886672
Phase 3Taking people
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Where
Alessandria, Bari, Catania, Chieti, Ferrara, Genova, Meldola, Mestre, Modena, Naples, Orbassano, Padova, Parma, Pavia, Reggio Emilia, Roma, Rozzano, Taranto, Trieste
Age
18 years and over
People
162
Run by
Gruppo Oncologico Italiano di Ricerca Clinica
See details and how to joinNCT04996017
No phaseTaking people
Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)
Where
Aviano
Age
18 years and over
People
52
Run by
Centro di Riferimento Oncologico - Aviano
See details and how to joinNCT06637345
No phaseTaking people
New Preclinical and Clinical Approaches to Mesothelioma
Where
Milan, Naples
People
70
Run by
Marco Emilio Bianchi
See details and how to joinNCT06536179